OGT to Develop Microarrays for HIV-AIDS Vaccine Research

Dec 05, 2006

NEW YORK (GenomeWeb News) - Oxford Gene Technology today said it will design an optimized oligonucleotide microarray for the Innate Discovery Team, part of the Center for IV-AIDS Vaccine Immunology.

The center will use the microarrays to study genes involved in the cellular immune response of early-stage HIV-infected patients.

OGT said the microarrays will be printed using its ink jet in situ synthesis platform for parallel analysis of multiple samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Featured White Papers

Compatibility of CYTAG CGH Labeling Kit with Illumina 24sure Microarrays

Optimized NGS Library Preparation with Acoustic Liquid Handling

Main menu